News

Endeavour Mining Engages in Major Share Buyback Initiative

Endeavour Mining Engages in Major Share Buyback Initiative

Endeavour Mining Engages in Major Share Buyback Initiative

Endeavour Mining plc has recently embarked on a significant transaction focusing on the repurchase of its own shares, as part of a broader strategy to reinforce shareholder value and demonstrate its confidence in the company’s future. This initiative follows their previously announced buyback program aimed at optimizing capital allocation.

Overview of the Share Purchase

The company executed the buyback program through a purchase on June 24, 2025, managed by Stifel Nicolaus Europe Limited. A total of 30,000 ordinary shares were acquired at a mix of prices, with the lowest recorded at 2,200.00 GBp and the highest at 2,292.00 GBp. The volume-weighted average price paid for the shares stood at 2,258.73 GBp. This strategic move is projecting a more robust capital framework and is indicative of Endeavour's proactive approach in capital management.

Cancellation and Impact on Shares

Following the cancellation of the repurchased shares, Endeavour will have no ordinary shares remaining in treasury, bringing the total to 241,855,962 ordinary shares issued. As a result, this figure will now serve as the denominator for shareholders to determine their notification requirements under the relevant FCA's Disclosure Guidance and Transparency Rules.

Validation of Buyback Program

This buyback initiative is directly aligned with Endeavour Mining's strategic growth plans outlined earlier in 2025. By lowering the number of shares in circulation, Endeavour not only improves its earnings per share metric but also sends a positive signal to investors regarding the company's financial health and growth trajectory.

Detailed Transaction Information

In compliance with market regulations, Endeavour Mining has provided transparent details of its share acquisition process. These transactions are an important aspect of maintaining corporate integrity and accountability. Each transaction carried out by Stifel Nicolaus Europe Limited is carefully documented to ensure compliance with all standard trading practices.

Insights from Individual Transactions

The company's shares were bought across multiple trades on the London Stock Exchange (LSE), with varied volumes reflecting the ebb and flow of market conditions. Transactions included purchases of 228 shares at the price of 2,286.00 GBp and larger blocks of up to 1,065 shares, reinforcing the commitment to both buyback execution and shareholder interests.

Endeavour Mining's Position in Gold Production

Endeavour Mining continues to stand as a prominent entity in the global gold production landscape, recognized not only as the largest gold producer in West Africa but also for its strong management and responsible mining practices. With operational assets spread across several countries, including Senegal and Côte d'Ivoire, the company is strategically positioned to harness the economic potential of the Birimian Greenstone Belt.

Commitment to Sustainable Practices

As a member of the World Gold Council, Endeavour Mining pledges to uphold sustainable mining practices, striving to create lasting value for all stakeholders including shareholders, employees, and the surrounding communities. Their initiatives reflect a commitment to balancing economic advancement while protecting the environment, aligning corporate governance with social responsibility.

Contact Endeavour Mining

For inquiries related to investor relations, please reach out to:

Jack Garman
Vice President of Investor Relations
+44 203 011 2723
investor@endeavourmining.com

For media related inquiries, contact:

Carole Cable
Brunswick Group LLP
+44 207 404 5959
ccable@brunswickgroup.com

Frequently Asked Questions

What is the purpose of Endeavour Mining’s share buyback?

Endeavour Mining’s share buyback aims to enhance shareholder value by reducing the number of shares in circulation, which typically increases earnings per share.

When did Endeavour Mining announce its buyback program?

The buyback program was announced earlier in 2025 to optimize capital allocation and reinforce market confidence in the company's future.

What was the average price paid per share during the buyback?

The volume-weighted average price paid per share was 2,258.73 GBp.

How many shares did Endeavour Mining repurchase in total?

A total of 30,000 ordinary shares were repurchased under the buyback initiative.

Who can shareholders contact for more information?

Shareholders can contact Jack Garman for investor inquiries or Carole Cable for media inquiries at Endeavour Mining for further information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading